Hide metadata

dc.date.accessioned2020-03-19T19:44:57Z
dc.date.available2020-03-19T19:44:57Z
dc.date.created2019-08-13T14:30:08Z
dc.date.issued2019
dc.identifier.citationDi Ruscio, Francesco Guzzetta, Giorgio Bjørnholt, Jørgen Leegaard, Truls Michael Moen, Aina Elisabeth Fossum Merler, Stefano De Blasio, Birgitte Freiesleben . Quantifying the transmission dynamics of MRSA in the community and healthcare settings in a low-prevalence country. Proceedings of the National Academy of Sciences of the United States of America. 2019, 116(29), 14599-14605
dc.identifier.urihttp://hdl.handle.net/10852/74086
dc.description.abstractMethicillin-resistant Staphylococcus aureus (MRSA) is a primarily nosocomial pathogen that, in recent years, has increasingly spread to the general population. The rising prevalence of MRSA in the community implies more frequent introductions in healthcare settings that could jeopardize the effectiveness of infection-control procedures. To investigate the epidemiological dynamics of MRSA in a low-prevalence country, we developed an individual-based model (IBM) reproducing the population’s sociodemography, explicitly representing households, hospitals, and nursing homes. The model was calibrated to surveillance data from the Norwegian national registry (2008–2015) and to published household prevalence data. We estimated an effective reproductive number of 0.68 (95% CI 0.47–0.90), suggesting that the observed rise in MRSA infections is not due to an ongoing epidemic but driven by more frequent acquisitions abroad. As a result of MRSA importations, an almost twofold increase in the prevalence of carriage was estimated over the study period, in 2015 reaching a value of 0.37% (0.25–0.54%) in the community and 1.11% (0.79–1.59%) in hospitalized patients. Household transmission accounted for half of new MRSA acquisitions, indicating this setting as a potential target for preventive strategies. However, nosocomial acquisition was still the primary source of symptomatic disease, which reinforces the importance of hospital-based transmission control. Although our results indicate little reason for concern about MRSA transmission in low-prevalence settings in the immediate future, the increases in importation and global circulation highlight the need for coordinated initiatives to reduce the spread of antibiotic resistance worldwide.
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleQuantifying the transmission dynamics of MRSA in the community and healthcare settings in a low-prevalence country
dc.typeJournal article
dc.creator.authorDi Ruscio, Francesco
dc.creator.authorGuzzetta, Giorgio
dc.creator.authorBjørnholt, Jørgen
dc.creator.authorLeegaard, Truls Michael
dc.creator.authorMoen, Aina Elisabeth Fossum
dc.creator.authorMerler, Stefano
dc.creator.authorDe Blasio, Birgitte Freiesleben
cristin.unitcode185,51,15,0
cristin.unitnameAvdeling for biostatistikk
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin1715631
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Proceedings of the National Academy of Sciences of the United States of America&rft.volume=116&rft.spage=14599&rft.date=2019
dc.identifier.jtitleProceedings of the National Academy of Sciences of the United States of America
dc.identifier.volume116
dc.identifier.issue29
dc.identifier.startpage14599
dc.identifier.endpage14605
dc.identifier.doihttps://doi.org/10.1073/pnas.1900959116
dc.identifier.urnURN:NBN:no-77194
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0027-8424
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/74086/1/DiRuscio_2019_Qua.pdf
dc.type.versionPublishedVersion
dc.relation.projectHSØ/2014002


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International